Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2008
12/31/2008WO2008112891A3 Monoclonal antibody that recognizes a seneca valley virus (svv) cellular receptor and uses thereof
12/31/2008WO2008112290A3 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
12/31/2008WO2008108805A3 Attenuated fnr deficient enterobacteria
12/31/2008WO2008103905A3 Antibodies that specifically bind irta and methods of use
12/31/2008WO2008100598A3 A method for enhancing t cell response
12/31/2008WO2008094849A3 Sugar immunogens
12/31/2008WO2008091954B1 Optimized cd40 antibodies and methods of using the same
12/31/2008WO2008091954A4 Optimized cd40 antibodies and methods of using the same
12/31/2008WO2008090319A3 Methods and biomarkers for diagnosing and monitoring psychotic disorders
12/31/2008WO2008084294A3 Methods of vaccine administration
12/31/2008WO2008056263A3 Quality control methods for oil-in-water emulsions containing squalene
12/31/2008WO2008039267A3 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
12/31/2008WO2007119011A9 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family
12/31/2008WO2007119011A8 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family
12/31/2008WO2007105218A3 Composition and method for brain tumor therapy
12/31/2008WO2007094893A9 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
12/31/2008WO2007094893A8 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
12/31/2008WO2007092735A3 An extracorporeal cell-based therapeutic device and delivery system
12/31/2008EP2009443A1 Diagnostic agent and therapeutic agent for pancreatic cancer
12/31/2008EP2009119A1 Compositions for treating cancer using viruses
12/31/2008EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease
12/31/2008EP2009101A1 Antibody modification method for purifying bispecific antibody
12/31/2008EP2009097A1 Normal prostate stem cells
12/31/2008EP2009028A1 Combination of a conventional anti-cancer treatment with anti-CD44 antibody administration for treating solid tumors
12/31/2008EP2009026A1 Anti-VPAC1 antibodies and their uses
12/31/2008EP2009025A1 Method of inhibiting osteoclast activity
12/31/2008EP2009000A1 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
12/31/2008EP2007899A2 Antibodies directed to angiopoietin-like protein 4 and uses thereof
12/31/2008EP2007872A1 Live attenuated salmonella vaccine
12/31/2008EP2007813A2 Agonist erythropoietin receptor antibodies
12/31/2008EP2007812A2 Erythropoietin receptor agonists
12/31/2008EP2007811A2 Targeted binding agents directed to upar and uses thereof
12/31/2008EP2007809A1 Glycosylated antibodies
12/31/2008EP2007807A2 Composition and method for mediating an immune response
12/31/2008EP2007798A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
12/31/2008EP2007793A1 Bacterial vaccine
12/31/2008EP2007602A2 Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemia
12/31/2008EP2007538A2 Binding partners with immunoglobulin domains modified to have extended half-life
12/31/2008EP2007428A2 Method for using boc/cdo to modulate hedgehog signaling
12/31/2008EP2007427A2 Improved vaccines comprising multimeric hsp60 peptide carriers
12/31/2008EP2007425A2 Methods for treating conditions associated with masp-2 dependent complement activation
12/31/2008EP2007424A2 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites
12/31/2008EP2007423A2 Ctla4 antibody combination therapy
12/31/2008EP2007422A1 Adjuvant
12/31/2008EP2007421A2 Vaccines comprising oligonucleotides having immunostimulatory sequences (iss) wherein the iss are conjugated to antigens and stabilized by buffer conditions and further excipients.
12/31/2008EP2007420A2 Recombinant attenuated clostridium organisms and vaccine
12/31/2008EP2007419A1 Vaccine against mycoplasma prrsv
12/31/2008EP2007418A1 Reversibly inhibited antibodies for immune cell stimulation
12/31/2008EP1761278B1 Adjuvant composition and methods for its use
12/31/2008EP1682666B1 HIV Pharmaceutical vaccines
12/31/2008EP1660536B1 FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY
12/31/2008EP1550457B1 Vaccine composition comprising interleukin-15 (il-15)
12/31/2008EP1549760B1 Sak: modulation of cellular proliferation for treatment of cancer
12/31/2008EP1490409B1 Modified saccharides having improved stability in water
12/31/2008EP1455817B1 Staphylococcus aureus exopolysaccharide and process
12/31/2008EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/31/2008EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
12/31/2008EP1305039B1 Stable (fixed) forms of viral l1 capsid proteins, fusion proteins and uses thereof
12/31/2008EP1294872B1 Human trp-like calcium channel protein-2 (tlcc-2)
12/31/2008EP1287152B1 Human-bovine chimeric respiratory syncytial virus vaccines
12/31/2008EP1272527B1 Preparation of antibodies having adcc via cd16, such as anti-rhesus d monoclonal antibodies
12/31/2008EP1165127B1 Multivalent dengue virus vaccine
12/31/2008EP1113810B1 Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding
12/31/2008EP1028751B1 Methods and compositions comprising glycoprotein glycoforms
12/31/2008EP0989863B1 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/31/2008EP0937153B1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
12/31/2008EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
12/31/2008CN101336249A 新型肽化合物 Novel peptide compounds
12/31/2008CN101336112A Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
12/31/2008CN101334356A Gas sensors
12/31/2008CN101333256A Human antibodies that bind human il-12 and methods for producing
12/31/2008CN101333255A BP180 single chain antibody of humanized anti-bullous pemphigoid antigen
12/31/2008CN101333248A B cell antigen epitope polypeptide of encephalitis B virus E protein and uses thereof
12/31/2008CN101333246A Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof
12/31/2008CN101333244A Protein purification by ion exchange chromatography
12/31/2008CN101332300A Dosages for treatment with anti-egfr antibodies
12/31/2008CN101332299A Dosages for treatment with anti-egfr antibodies
12/31/2008CN101332298A Bivalent vaccine for pig and preparation method thereof
12/31/2008CN101332297A Preparation method of novel subunit vaccine of pig pseudorabies
12/31/2008CN101332296A Dendritic cell vaccine for promoting spinal cord injury function recovery
12/31/2008CN100447247C Recombinant infectious non-segmented negative strand RNA virus
12/31/2008CN100447244C BAFF receptor (BCMA), immunoregulatory agent
12/31/2008CN100447159C Antibodies to ED-8 domain of fibronectin, their construction and uses
12/31/2008CN100447158C Neutralizable epitope of HGF and neutralizing antibody binding to the same
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100446813C Hepatitis A-hepatitis E combined vaccine and preparation method thereof
12/31/2008CN100446812C MVA expressing modified HIV envelope, GAG, and pol genes
12/31/2008CN100446811C Composition comprising immunogenic microparticles
12/31/2008CA2698143A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
12/31/2008CA2692332A1 Method for detection or treatment of graft versus host disease
12/31/2008CA2692263A1 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
12/31/2008CA2692200A1 Low-additive influenza vaccines
12/31/2008CA2692165A1 Compositions of specific binding agents to hepatocyte growth factor
12/31/2008CA2691785A1 Complexes of il-15 and il-15ralpha and uses thereof
12/31/2008CA2691784A1 Composition and method for treatment of autoimmune disease
12/31/2008CA2691745A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
12/31/2008CA2691702A1 Mitogen activated protein kinase modulator
12/31/2008CA2691166A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
12/31/2008CA2691054A1 Combinations of sap depleting agents and anti-sap antibodies
12/31/2008CA2690888A1 Cancer therapeutic composition comprising antibody against peptide encoded by exon-17 site of periostin
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 1823